HOB Biotech Group Corp Ltd Cash Flow-to-Debt Ratio
HOB Biotech Group Corp Ltd cash flow-to-debt ratio. HOB Biotech Group Corp Ltd (688656) has a Cash Flow-to-Debt Ratio of 0.14x as of December 2025, meaning its operating cash flow of CN¥15.28 Million could theoretically repay 0% of its total liabilities (CN¥111.30 Million) in one year. Check HOB Biotech Group Corp Ltd (688656) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of HOB Biotech Group Corp Ltd (2016–2025)
Cash flow-to-debt ratio of HOB Biotech Group Corp Ltd from 2016 to 2025. Historical debt coverage capacity for HOB Biotech Group Corp Ltd across 10 annual periods. Check HOB Biotech Group Corp Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
HOB Biotech Group Corp Ltd Cash Flow-to-Debt Ratio by Year (2016–2025)
HOB Biotech Group Corp Ltd cash flow-to-debt ratio by year from 2016 to 2025. Year-by-year debt coverage analysis for HOB Biotech Group Corp Ltd. For the full cash flow conversion analysis, see cash flow conversion of HOB Biotech Group Corp Ltd.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.66x | CN¥72.94 Million | CN¥111.30 Million | ▲ +42.9% |
| 2024 | 0.46x | CN¥101.22 Million | CN¥220.67 Million | ▼ -38.1% |
| 2023 | 0.74x | CN¥102.69 Million | CN¥138.52 Million | ▲ +109.8% |
| 2022 | 0.35x | CN¥58.31 Million | CN¥164.99 Million | ▼ -68.3% |
| 2021 | 1.12x | CN¥104.79 Million | CN¥93.92 Million | ▲ +72.5% |
| 2020 | 0.65x | CN¥58.22 Million | CN¥90.02 Million | ▲ +25.9% |
| 2019 | 0.51x | CN¥68.57 Million | CN¥133.54 Million | ▲ +1.7% |
| 2018 | 0.50x | CN¥46.51 Million | CN¥92.10 Million | ▲ +47.9% |
| 2017 | 0.34x | CN¥22.26 Million | CN¥65.20 Million | ▲ +261.2% |
| 2016 | 0.09x | CN¥6.42 Million | CN¥67.94 Million | — |